TY - JOUR T1 - Health-care workers in gastrointestinal endoscopy are at higher risk for SARS-CoV-2 infection compared to other aerosol-generating disciplines JF - medRxiv DO - 10.1101/2021.09.20.21263566 SP - 2021.09.20.21263566 AU - Christoph Römmele AU - Alanna Ebigbo AU - Maria Kahn AU - Stephan Zellmer AU - Anna Muzalyova AU - Gertrud Hammel AU - Christina Bartenschlager AU - Albert Beyer AU - Jonas Rosendahl AU - Tilo Schlittenbauer AU - Johannes Zenk AU - Bilal Al-Nawas AU - Roland Frankenberger AU - Jürgen Hoffmann AU - Christoph Arens AU - Frank Lammert AU - Claudia Traidl-Hoffmann AU - Helmut Messmann Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/22/2021.09.20.21263566.abstract N2 - Objective Healthcare workers (HCW) are at high risk of SARS-CoV-2 infection due to exposure to potentially infectious material, especially during aerosol-generating procedures (AGP). We aimed to investigate the prevalence of infection among HCW in medical disciplines with AGP.Design A nationwide questionnaire-based study in in- and outpatient settings was conducted between 12/16/2020 and 01/24/2021. Data on SARS-CoV-2 infections among HCW and potential risk factors were investigated.Results 2,070 healthcare facilities with 25,113 employees were included in the study. Despite a higher rate of pre-interventional testing, clinics treated three times more confirmed SARS-CoV-2 cases than private practices (28.8% vs. 88.4%, p<0.001). Overall infection rate among HCW accounted for 4.7%. Multivariate analysis revealed that ZIP-regions having comparably higher incidences were significantly associated with increased risk of infection. Furthermore, clinical setting and the GIE specialty have more than double the risk of infection (OR 2.63; 95% CI 2.501-2.817, p<0.01 and OR 2.35; 95% CI 2.245-2.498, p<0.01). The number of procedures performed per day was also significantly associated with an increased risk of infection (OR 1.01; 95% CI 1.007-1.014), p<0.01). No treatment of confirmed SARS-CoV-2 cases was tending to lower the risk of infection (OR 0.72; 95% CI 0.507-1.025, p=0.068).Conclusion HCW in GIE seem to be at higher risk of infection than those in other AGP, especially in the clinical setting. Regions having comparably higher incidences as well as the number of procedures performed per day were also significantly associated with increased risk of infection.What is already known on this subject?Health care workers, especially those exposed to aerosol generating procedures, are assumed to have an increased risk of SARS-CoV-2 infection. However, data confirming this are lacking, especially for the outpatient care setting.What are the new findings?Health care workers in gastrointestinal endoscopy have a higher risk of SARS-CoV-2-infection than in other AGPs. This risk is particularly higher- in clinical settings compared to private practices- in regions having comparably higher incidences- the more procedures are performed per dayHow might it impact on clinical practice in the foreseeable future?Our study suggests making additional efforts to protect HCW in the gastrointestinal work field.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received public funds by B-FAST of the Network of University Medicine (NUM) (Award/Grant Number: 01KX2021) and Bavarian State Ministry for Science and Arts (Award/Grant Number: 152820012).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practices. An approval of the study was given by the Ethics Committee of the University Hospital of Augburg (713/20 S-SR).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request. ER -